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a  b  s  t  r  a  c  t
INTRODUCTION:  Today,  pancreatic  surgery  can  be  performed  with  low  mortality  and  tolerable  morbid-
ity in  specialized  centers.  Nevertheless,  due  to  its anatomical  localization  and  proximity  to  important
vascular  structures,  surgical  resection  of  the  pancreas  remains  challenging  in  many  cases.
PRESENTATION  OF  CASE:  Here,  we present  the case  of  a young  woman  who  presented  in our department
with  abdominal  pain  and  a tumor  mass  located  at  the  pancreatic  head.  She  had  undergone  explorative
laparotomy  elsewhere  before,  in which  the  pancreatic  tumor  mass  was  reported  to  be  unresectable  due
to inﬁltration  of the  mesenteric  root.  However,  biopsies  obtained  had  not  revealed  malignancy.  More-
over,  postoperatively  a  stenting  of  the  portal  vein  had  been  performed  due  to portal  vein  thrombosis
and  varices.  Upon  admission  in our  clinic,  computed  tomography  revealed  a tumor  of the pancreatic
head,  occlusion  of  the portal vein  stent  and, more  importantly,  extravascular  dislocation  of  the  stent
with  perforation  into  the  stomach.  Upon  explorative  laparotomy  we initially  performed  a mesenterico-
caval  shunt  to release  portal  hypertension.  Secondly,  the dislocated  stent  was  successfully  removed
upon  gastrotomy,  and  ﬁnally,  a partial  pancreaticoduodencectomy  was  performed.  Interestingly,  the
histopathological  analysis  revealed  granulocytic  epithelial  lesions  (GELs)  conﬁrming  a type-2  autoim-
mune  pancreatitis  without  evidence  for malignancy.  The  postoperative  course  was  uneventful  and  the
patients  was  dismissed  without  any  remaining  symptoms.
DISCUSSION  & CONCLUSION:  This  interesting  and  unique  case  underlines  the complexity  in  diagnosis
of  pancreatic  tumors  with  unsolved  dignity  and  differential  diagnosis  of  pancreatitis  and  pancreatic
cancer.  Furthermore,  it demonstrated  the challenges  in pancreatic  surgery  for exceptional  and  uncommon
conditions  demanding  complex  surgical  approaches.
©  2016  The  Author(s).  Published  by  Elsevier  Ltd  on behalf  of IJS  Publishing  Group  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
Pancreatic tumors comprise benign lesions and malignant
eoplasms, most importantly adenocarcinomas arising from the
ancreatic ducts [1]. Pancreatic ductal adenocarcinomas have a
ismal prognosis with a 5-year survival rate of about 5% [2]. The
nly chance for cure is provided by surgical resection which is the
herapy of choice for suspected, resectable pancreatic cancer [3].
espite major improvement in radiological diagnostic, preopera-
ive differentiation between pancreatic cancer and benign lesions
ncluding chronic pancreatitis remains imperfect in many cases [4].
The area of major pancreatic surgery arose at the turn of the
9th and 20th century when the ﬁrst distal pancreatectomy and
rst partial pancreaticoduodenectomy had been successfully per-
ormed [5]. However, until the 1980s pancreatic resection was still
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associated with perioperative mortality up to 30% and signiﬁcant
morbidity [5]. Therefore, the actual beneﬁt of major pancreatic sur-
gical approaches had been a matter of debate for long time. Due
to establishment of high volume centers with experienced pan-
creatic surgeons and major advances in intensive care treatment
mortality has dropped below 5% since the 1980s [6]. Consequently,
today surgery provides a safe therapeutic approach for pancre-
atic conditions, most importantly for pancreatic tumor of unsolved
or conﬁrmed malignant dignity [7]. However, due to its anatom-
ical proximity to main vascular structures such as coeliac trunk,
superior mesenteric artery and mesenteric/portal vein, pancreatic
resection remains a major challenge in surgery. In particular this
holds true in cases that require complex vascular re-construction
upon resection, which usually also determine limitations in pancre-
atic surgery [8]. Here, we present a unique cases in which partial
pancreatectomy in combination with mesenterico-caval shunt was
required for an unclear mass of the pancreatic head with portal-
caval collateralization and extravascular dislocation of a previously
implanted portal vein stent.
oup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. (A) computed tomography scan revealed the pancreatic mass of unknownCASE  REPORT
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. Presentation of case
We  report on a 19 year-old woman who had been primarily
dmitted to the department of internal medicine in April 2011 with
he history of pancreatitis of unclear nature 4 months before. The
atient reported an uneventful medical history without preexisting
onditions or traumas in the past and there was no family history
f autoimmune diseases. The patient was not under any long-term
edication. Moreover, there was no evidence for alcohol or drug
buses. At that time a computed tomography had revealed a portal
ein thrombosis as well as a tumor mass located at the pancreatic
ead suspicious for pancreatic cancer. Subsequently, the patient
as referred to an external surgical center where an explorative
aparotomy was performed. Intraoperatively, the tumor mass was
egarded to be unresectable due to tumor inﬁltration of the mesen-
eric root and, subsequently, multiple biopsies of the tumor mass
ere obtained. Postoperatively, a portal venous stent was  placed
nterventionally due to portal vein thrombosis and varices. Inter-
stingly, at that time the pancreatic biopsies did not reveal any
vidence for malignancy and the patient was dismissed with the
iagnosis of a chronic pancreatitis of unknown speciﬁcity.
In March 2015 the patient reported on abdominal pain. Imaging
onﬁrmed the diffuse and large tumor mass located at the pancre-
tic head being constant in size compared to previous CT scans
ith intra- and extrahepatic cholestasis. However, in addition,
cclusion of the portal vein stent was detected with pronounced
ortal-systemic collateralization and varices. Intriguingly, the pre-
iously implanted portal vein stent was found to be dislocated
ith perforation into the stomach (Fig. 1). Carbohydrate-Antigen
9.9. (CA19.9) was slightly elevated at that time. Subsequently,
he patient was admitted to our surgical clinic for further treat-
ent. In summary, we were confronted with (i) a pancreatic tumor
ith still unsolved dignity with compression of the duodenum
nd cholestasis (ii) occlusion of the previously implanted portal
ein stent with portal-systemic collateralization and varices, and
iii) extravascular dislocation of a portal vein stent with pene-
ration into the stomach. Although, retrospectively, the existence
f a pancreatic adenocarcinoma already a time of ﬁrst explo-
ative laparotomy in 2011 was highly unlikely, the progression
o a malignant tumor on the basis of chronic pancreatitis had
o be considered, in particular due to increasing symptoms and
holestasis. Moreover, the dislocated portal venous stent was  asso-
iated with a high risk of contamination with consecutive sepsis
s well as acute hemorrhage. Moreover, interventional release
f cholestasis by endoscopic retrograde cholangiography (ERC)
ppeared unfeasible due to duodenal compression. Upon discus-
ion this complex case in an interdisciplinary meeting we  decided
n a surgical approach with the aim to (i) ultimately conﬁrm dig-
ity of the pancreatic tumor mass, (ii) release portal hypertension
o alleviate esophageal varices, (iii) ensure biliary drainage and
astro-intestinal passage, and (iv) allow for recovery of the dis-
ocated stent. Upon explorative laparotomy we ﬁrstly exposed
he portal vein and the mesenteric root by carefully transecting
ll varices. In the next step a mesenterico-caval shunt to release
he portal hypertension and congestion of the small intestine was
erformed by direct mesenterico-caval anastomosis after careful
issection and mobilization of all structures of the mesenteric
oot. Having successfully accomplished this, we dissected the hep-
toduodenal ligament to identify the portal vein, hepatic artery
nd central bile duct. Subsequently the dislocated and stomach-
enetrating stent was removed (Fig. 2). The portal vein was ligated
ecause of the minimal residual ﬂow in the mainly occluded ves-
el. Finally, a partial duodenopancreatectomy and resection of
he distal stomach (including the perforation site) with hepatico-
ejunostomy and gastro-jejunostomy were performed to achieve
ltimate cure for the unclear pancreatic mass. Due to ﬁbrotic alter-origin. The white arrow indicated the previously implanted portal vein stein
penetrating the stomach. (B) A vascular reconstruction revealed pronounced porto-
systemic varices.
ation of the pancreatic tissue the pancreatic duct could not be
identiﬁed and the pancreatic stump oversewn with non-absorbable
sutures was blindly closed by stiches. Postoperatively, the patient
was monitored on our intensive care unit. The further clinical
course was uneventful. Pathological analysis revealed a pancreati-
tis with acinar atrophy, ductal ecstasy and inﬂammatory exudate
without evidence for malignancy. Intriguingly, further histopatho-
logical analysis detected granulocytic epithelial lesion (GELs), a
hallmark for a type-2 autoimmune pancreatitis (AIP). The patient is
currently followed-up in our department. Postoperatively all symp-
toms vanished and the patient enjoys a good quality of life.
3. Discussion
This interesting and very unique case report demonstrates, on
the one hand, the complexity and complicacy in the diagnosis
of (autoimmune) pancreatitis compared to benign and malignant
tumors of the pancreas. On the other hand, it highlights the techni-
cally challenges (and possibly limits) which may be encountered
in pancreatic surgery. AIP is a very rare and benign inﬂamma-
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aig. 2. (A) Intraoperative images show the removed stent penetrating the stomach
white arrow). (B) White arrow indicates the mesenterico-caval shunt.
ory condition of the pancreas and comprises two subtypes, type-1
nd typ-2 AIP [9]. Both types have in common they are associ-
ted with immune cell inﬁltration in the pancreas leading to an
uto-inﬂammatory response. Although both subtypes are consid-
red to differ in epidemiological, immunological and pathological
eatures such as the type of immune cell inﬁltration, both have in
ommon that patients commonly respond to steroid treatment.
his matter of fact may  be also helpful as a diagnostic tool to
istinguish AIP from pancreatic of other origin [10]. Preopera-
ively a steroid treatment was initiated in our patient which led
o some clinical response in terms of decreasing cholestasis which
upported the diagnosis of AIP. Postoperatively, the histopatholog-
cal detection of GEL in the specimen upon resection conﬁrmed
he diagnosis von type-2 AIP. However, preoperatively, a pancre-
tic malignancy could not be deﬁnitely excluded in the performedPEN  ACCESS
ery Case Reports 29 (2016) 151–154 153
diagnostic. Moreover, a primary surgical approach was pursued in
our case because of the portal vein thrombosis with progressive
portal-caval transformation and varices, and in addition, a dislo-
cated and stomach-penetrating portal vein stent. Upon explorative
laparotomy we performed a combination of two itself unquestion-
able complex surgical procedures: a mesenterico-caval shunt and
a partial duodenopancreatectomy. This approach was further com-
plicated by pronounced cavernous transformation and varices as
well as a dislocation of a stomach inﬁltrating stent which had to be
recovered.
4. Conclusion
To our knowledge this case report is the ﬁrst description of
this extremely challenging combination of above described surgi-
cal procedures. In conclusion, this report highlights challenges in
pancreatic surgery which, however, may  be successfully overcome
by complex surgical strategies reported here.
Written informed consent was obtained from the patient for
publication of this case report and accompanying images. A copy of
the written consent is available for review by the Editor-in-Chief of
this journal on request. This case report is in line with the SCARAE
criteria [11]. All author declare no conﬂict of interest.
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